Skip to main content
. 2017 Jan 3;12(1):e0169147. doi: 10.1371/journal.pone.0169147

Fig 2. Kaplan-Meier estimated the effect of genotype of rs1801131 and dosimetric parameters on cumulative RP probability.

Fig 2

(A) Patients with TT genotype of rs1801131 and MLD >11.6Gy had higher risk of ≥ 2 RP compared with GG/GT genotypes (P<0.001). (B) Patients with TT genotype of rs1801131 and V20 >17.1% had higher risk of ≥ 2 RP compared with GG/GT genotypes(P<0.001).